The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Head And Neck Cancer Diagnostics Global Market Report 2023, the head and neck cancer diagnostics market is expected to show significant growth in the forecast period.

Key insights from the head and neck cancer diagnostics market forecast include:

1. Market Size
   The global head and neck cancer diagnostics market is anticipated to increase from $1.27 billion in 2022 to $1.51 billion in 2023, with an 18.6% CAGR. By 2027, the market size is forecasted to reach $2.84 billion, growing at a 17.2% CAGR.

2. Major Driver
   The increasing head and neck cancer cases are set to drive the head and neck cancer diagnostics market. For example, in February 2023, the American Society of Clinical Oncology reported that head and neck cancer constituted 4% of all US malignancies. In the USA, 66,920 individuals are expected to be affected in 2023 (49,190 men and 17,730 women), while worldwide, 562,328 cases were noted in 2020. Additionally, Australia recorded 5,189 new cases of head and neck cancer in 2022. Consequently, the growing incidence of head and neck cancer fuels market growth.

View More On The Head And Neck Cancer Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-diagnostics-global-market-report

3. Key Trend
   Product innovation is a prominent trend in head and neck cancer diagnostics. Leading market players focus on creating novel products for a stronger market presence. For example, in May 2023, India’s Alkem Laboratories Ltd. introduced Cetuxa, the world’s first biosimilar for head and neck cancer treatment. Cetuxa, akin to cetuximab, an anti-tumor monoclonal antibody, targets the epidermal growth factor receptor’s extracellular domain. It is commonly used in conjunction with chemotherapy or radiation therapy to treat locally advanced, recurrent, or metastatic squamous cell carcinoma of the head and neck.

4. Largest Region
   North America was the largest region in the head and neck cancer diagnostics market in 2022.

5. Major Players
   Major players in the head and neck cancer diagnostics market are F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Co., Abbott Laboratories, Siemens Healthineers AG, BioNTech AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Laboratory Corporation of America, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Shimadzu Corporation, Sysmex Corp., Varian Medical Systems Inc., QIAGEN N.V., Exact Sciences Corp., Bio-Techne Corp., Carestream Health Inc., Myriad Genetics Inc., Cepheid Inc., Invitae Corporation, Accuray Inc., Canon Medical Systems Corporation, NanoString Technologies Inc, Asuragen Inc., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc., Oncgnostics GmbH, Perseus Proteomics Inc., and VolitionRx Ltd.

Request A Sample Of The Global Head And Neck Cancer Diagnostics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12016&type=smp

Key Head And Neck Cancer Diagnostics Market Segments
The global head and neck cancer diagnostics market is segmented –
1) By Diagnostic Method: Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Biopsy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods
2) By Channel: Retail and Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies
3) By End-User: Hospitals, Diagnostic Centers, Other End Users

The Head And Neck Cancer Diagnostics Global Market Report 2023  provides an in-depth analysis on the head and neck cancer diagnostics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the head and neck cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Head And Neck Cancer Therapeutics Global Market Report 2023
Cancer Diagnostics Global Market Report 2023
LINAC Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model